Salbutamol/Budesonide Inhalation Spray (Airsupra) Price Details and Purchase Channels

Albuterol/Budesonide Airsupra is a prescription combination rescue inhaler designed to be used as needed to reduce the risk of asthma attacks. Airsupra is designed to combine two drugs, the short-acting/fast-acting beta2-adrenergic agonist (SABA) albuterol sulfate, and the inhaled corticosteroid (ICS) budesonide. This combination is delivered as a spray into the respiratory tract via an oral inhaler, providing fast and effective wheezing relief.

Albuterol sulfate, aSABA drug, helps relax the smooth muscles of the airways, allowing the airways to dilate, allowing the patient to breathe more easily. Its mechanism of action is by activating β2-adrenergic receptors, promoting the relaxation of airway smooth muscles, and quickly relieving asthma symptoms such as airway tightening, wheezing and shortness of breath. At the same time, budesonide, as an ICS drug, can effectively reduce lung inflammation. Inflammation of the lungs is often one of the main causes of breathing difficulties and worsening of asthma symptoms, so by reducing this inflammation, budesonide can help patients improve their overall respiratory function.

Airsupra is a rescue inhaler that can be used as needed to treat or prevent asthma symptoms. This medication can be used quickly when patients experience airway discomfort, wheezing, or shortness of breath. The dosage is 2 inhalations each time, and patients should not take more than 12 inhalations (i.e. 6 doses) in a 24-hour period to ensure safe and effective symptom control without leading to overuse or an increase in drug side effects.

AlthoughAirsupra is very effective in acute situations, it is important to note that it is not suitable for maintenance treatment of asthma. For those patients who require long-term control of their asthma symptoms, they will still need to continue using their long-term medications as directed by their healthcare provider. These long-term medications often include other types of ICS or long-acting beta2-adrenergic agonists (LABA), designed to provide sustained symptom control and inflammation management.

In general,Airsupra provides a convenient first aid option for asthma patients. Its dual action mechanism can effectively deal with sudden breathing problems, providing patients with more security and flexibility in their daily lives. However, patients should always follow medical advice when using it, ensure rational use of medications, and communicate with their doctors regularly to adjust treatment plans and optimize asthma management. With proper use, Airsupra can help patients better control their asthma and improve their quality of life.

Currently, albuterol/budesonide inhalation spray has not yet been launched in China, and domestic patients cannot directly purchase this drug for the time being. If patients want to know more about this drug, they can consult with the medical consultant.

Reference link:https://www.drugs.com/airsupra.html